نمایش پرونده ساده آیتم

dc.contributor.authorAsadi, N
dc.contributor.authorDavaran, S
dc.contributor.authorPanahi, Y
dc.contributor.authorHasanzadeh, A
dc.contributor.authorMalakootikhah, J
dc.contributor.authorMoafi, HF
dc.contributor.authorAkbarzadeh, A
dc.date.accessioned2018-08-26T07:20:50Z
dc.date.available2018-08-26T07:20:50Z
dc.date.issued2017
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/45996
dc.description.abstractThe cancer immunotherapy method uses the specificity of the immune system to provide a more effective than more conventional treatments, such as chemotherapy and radiotherapy. Immunotherapy has two main strategies (passive or active) to organize the immune system. Passive strategies use advantage of tumor-hyperpermeable cells, which have enhanced permeability and retention effects. Nanoparticles due to their better accumulation within tissues and cells of the immune system are well suitable for delivery of immune therapies such as vaccines or adjuvants. In this review, we explained application of nanotechnology in immunotherapy of cancer.
dc.language.isoEnglish
dc.relation.ispartofARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
dc.subjectCancer
dc.subjectchemotherapy
dc.subjectEPR
dc.subjectimmunotherapy
dc.titleApplication of nanostructured drug delivery systems in immunotherapy of cancer: a review
dc.typeReview
dc.citation.volume45
dc.citation.issue1
dc.citation.spage18
dc.citation.epage23
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.1080/21691401.2016.1178136


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم